Ameriprise
MDRX

Ameriprise’s Veradigm Inc. Common Stock MDRX Stock Holding History

Ameriprise’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-528,182
Closed -$5.54M – 4004
2023
Q4 		$5.54M Sell
528,182
-7,181
-1% -$88K ﹤0.01% 2272
2023
Q3 		$7.03M Sell
535,363
-87,620
-14% -$1.15M ﹤0.01% 2008
2023
Q2 		$7.85M Sell
622,983
-25,640
-4% -$311K ﹤0.01% 1995
2023
Q1 		$8.46M Buy
648,623
+85,521
+15% +$1.38M ﹤0.01% 1906
2022
Q4 		$9.93M Sell
563,102
-25,784
-4% -$432K ﹤0.01% 1744
2022
Q3 		$8.97M Buy
588,886
+96,437
+20% +$1.56M ﹤0.01% 1774
2022
Q2 		$7.3M Sell
492,449
-72,007
-13% -$1.35M ﹤0.01% 2005
2022
Q1 		$12.7M Buy
564,456
+40,014
+8% +$811K ﹤0.01% 1702
2021
Q4 		$9.68M Sell
524,442
-1,772
-0.3% -$28.1K ﹤0.01% 2009
2021
Q3 		$7.04M Sell
526,214
-92,688
-15% -$1.5M ﹤0.01% 2140
2021
Q2 		$11.5M Sell
618,902
-56,237
-8% -$947K ﹤0.01% 1832
2021
Q1 		$10.1M Sell
675,139
-115,085
-15% -$1.84M ﹤0.01% 1877
2020
Q4 		$11.4M Sell
790,224
-210,310
-21% -$2.55M ﹤0.01% 1650
2020
Q3 		$8.14M Sell
1,000,534
-6,779
-0.7% -$55.4K ﹤0.01% 1702
2020
Q2 		$6.82M Buy
1,007,313
+432,513
+75% +$2.8M ﹤0.01% 1829
2020
Q1 		$4.05M Buy
574,800
+22,397
+4% +$182K ﹤0.01% 2048
2019
Q4 		$5.42M Sell
552,403
-4,068
-0.7% -$42.8K ﹤0.01% 2189
2019
Q3 		$6.11M Buy
556,471
+19,739
+4% +$203K ﹤0.01% 2076
2019
Q2 		$6.24M Sell
536,732
-34,226
-6% -$348K ﹤0.01% 2081
2019
Q1 		$5.45M Sell
570,958
-555,951
-49% -$6.14M ﹤0.01% 2165
2018
Q4 		$10.9M Sell
1,126,909
-27,042
-2% -$302K 0.01% 1532
2018
Q3 		$16.4M Buy
1,153,951
+94,709
+9% +$1.29M 0.01% 1460
2018
Q2 		$12.7M Sell
1,059,242
-92,458
-8% -$1.14M 0.01% 1535
2018
Q1 		$14.2M Buy
1,151,700
+14,065
+1% +$200K 0.01% 1366
2017
Q4 		$16.6M Buy
1,137,635
+184,710
+19% +$2.57M 0.01% 1211
2017
Q3 		$13.6M Buy
952,925
+439,489
+86% +$5.69M 0.01% 1340
2017
Q2 		$6.55M Buy
513,436
+33,717
+7% +$409K ﹤0.01% 1877
2017
Q1 		$6.08M Buy
479,719
+5,586
+1% +$66.2K ﹤0.01% 1890
2016
Q4 		$4.84M Buy
474,133
+7,092
+2% +$80.9K ﹤0.01% 2078
2016
Q3 		$6.15M Buy
467,041
+7,361
+2% +$98.4K ﹤0.01% 1825
2016
Q2 		$5.84M Buy
459,680
+10,460
+2% +$139K ﹤0.01% 1823
2016
Q1 		$5.93M Sell
449,220
-834
-0.2% -$10.9K ﹤0.01% 1823
2015
Q4 		$6.92M Sell
450,054
-8,187
-2% -$117K ﹤0.01% 1744
2015
Q3 		$5.68M Sell
458,241
-125,777
-22% -$1.73M ﹤0.01% 1928
2015
Q2 		$7.99M Buy
584,018
+8,081
+1% +$109K ﹤0.01% 1779
2015
Q1 		$6.89M Buy
575,937
+12,017
+2% +$147K ﹤0.01% 1878
2014
Q4 		$7.2M Sell
563,920
-311,863
-36% -$3.97M ﹤0.01% 1786
2014
Q3 		$11.7M Sell
875,783
-290,527
-25% -$4.4M 0.01% 1327
2014
Q2 		$18.7M Sell
1,166,310
-117,958
-9% -$1.84M 0.01% 1070
2014
Q1 		$23.2M Sell
1,284,268
-590,887
-32% -$10.2M 0.01% 902
2013
Q4 		$29M Sell
1,875,155
-255,825
-12% -$3.77M 0.02% 782
2013
Q3 		$31.7M Buy
2,130,980
+758,826
+55% +$11.4M 0.02% 754
2013
Q2 		$17.8M Buy
+1,372,154
New +$18.4M 0.01% 1046

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameriprise's MDRX Position: Q1 2024 in Review

Ameriprise sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 528,182 shares — an estimated $5.54M sold.

Ameriprise first reported a position in MDRX in Q2 2013 and held it in 43 quarters. The position peaked at $31.7M in Q3 2013. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Ameriprise reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ameriprise sold 528,182 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $5.54M.
  • Ameriprise first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 43 quarters.
  • Ameriprise's Veradigm Inc. Common Stock position peaked at $31.7M in Q3 2013.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.